Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion

Nicotine and Tobacco Research

Volumn 7, Issue 2, 2005, Pages 257-268

  Wileyto, E Paul ^a   Patterson, Freda ^a   Niaura, Raymond ^b   Epstein, Leonard H ^c   Brown, Richard A ^b   Audrain McGovern, Janet ^a   Hawk Jr , Larry W ^c   Lerman, Caryn ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REGRESSION ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; SMOKING CESSATION; SMOKING HABIT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TOBACCO DEPENDENCE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DELAYED-ACTION PREPARATIONS; DEPRESSION; DISTRICT OF COLUMBIA; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NEW YORK; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RHODE ISLAND; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 18044386817     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200500055673     Document Type: Article

References (37)

1. Abrams, D. B., Monti, P. M., Pinto, R. P., Elder, J. P., Brown. R. A., & Jacobus, S. I. (1987). Psychosocial stress and coping in smokers who relapse or quit. Health Psychology, 6, 289-303.
2. Ahluwalia, J. S., Harris, K. J., Catley, D., Okuyemi, K. S., & Mayo, M. S. (2002). Sustained-release bupropion for smoking cessation in African Americans: A randomized controlled trial. The Journal of the American Medical Association, 288, 468-474.
3. Anda, R., Williamson, D., Escobedo, L., Mast, E., Giovino, G., & Remington, P. (1990). Depression and the dynamics of smoking. The Journal of the American Medical Association, 264, 1541-1545.
4. Brown, R. A., Burgess, E. S., Sales, S. D., Whiteley, J. A., Evans, D., & Miller, I. W. (1998). Reliability and validity of a smoking timeline follow-back interview. Psychology of Addictive Behaviors, 12, 101-112.
5. Brown, R. A., Kahler, C. W., Niaura, R., Abrams, D. B., Sales, S. D., Ramsey, S. E., Goldstein, M. G., Burgess, E. S., & Miller, I. W. (2001). Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology, 69, 471-480.
6. Collins, B. N., Wileyto, E. P., Patterson, F., Rukstalis, M., Audrain-McGovern, J., Kaufmann, V., Pinto, A., Hawk, L., Niaura, R., Epstein, L. H., & Lerman, C. (2004). Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine & Tobacco Research, 6, 27-37.
7. Cousins, M. S., Stamat, H. M., & de Wit, H. (2001). Acute doses of d-amphetamine and bupropion increase cigarette smoking. Psychopharmacologia, 157, 243-253.
8. Covey, L. S., Glassman, A. H., & Stetner, F. (1990). Depression and depressive symptoms in smoking cessation. Comprehensive Psychiatry, 31, 350-354.
9. Dale, L. C., Glover, E. D., Sachs, D. P., Schroeder, D. R., Offord, K. P., Croghan, I. T., & Hurt, R. D. (2001). Bupropion for smoking cessation: Predictors of successful outcome. Chest, 119, 1357-1364.
10. Gonzales, D., Bjornson, W., Durcan, M. J., White, J. D., Johnston, J. A., Buist, A. S., Sachs, D. P., Rigotti, N. A., Niaura, R., Hays, J. T., & Hurt, R. D. (2002). Effects of gender on relapse prevention in smokers treated with bupropion SR. American Journal of Preventive Medicine, 22, 234-239.
11. Hall, S. M., Rugg, D., Tunstall, C., & Jones, R. T. (1984). Preventing relapse to cigarette smoking by behavioral skill training. Journal of Consulting and Clinical Psychology, 52, 372-382.
12. Hatsukami, D., Skoog, K., Allen, S., & Bliss, R. (1995). Gender and the effects of different doses of nicotine gum on tobacco withdrawal symptoms. Experimental and Clinical Psychopharmacology, 3, 163-173.
13. Hays, J., Hurt, R., Rigotti, N., Niaura, R., Gonzales, D., Durcan, M., Sachs, D. P., Wolter, T. D., Buist, A. S., Johnston, J. A., & White, J. D. (2001). Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized controlled trial. Annals of Internal Medicine, 135, 423-433.
14. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.
15. Hosmer, D. W., & Lemeshow, S. (1999). Applied survival analysis: Regression modeling of time to event data (1st ed.). New York: Wiley.
16. Hougaard, P. (2000). Analysis of multivariate survival data. New York: Springer-Verlag.
17. Hughes, J. R., Keely, J. P., Niaura, R., Ossip-Klein, D. J., Richmond, R. L., & Swan, G. E. (2003). Measure of abstinence in clinical trials: Issues and recommendations. Nicotine & Tobacco Research, 5, 13-25.
18. Hurt, R., Wolter, T., Rigotti, N., Hays, J. T., Niaura, R., Durcan, M. J., Gonzales, D., Sachs, D. P., Johnston, J. A., & Offord, K. P. (2002). Bupropion for pharmacologic relapse prevention to smoking: Predictors of outcome. Addictive Behaviors, 27, 493-507.
19. Hurt, R. D., Sachs, D. P., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., Croghan, I. T., & Sullivan, P. M. (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. The New England Journal of Medicine, 337, 1195-1202.
20. Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., Fiore, M. C., & Baker, T. B. (1999). A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. The New England Journal of Medicine, 340, 685-691.
21. Kelly, P. J., & Lim, L. L. (2000). Survival analysis for recurrent event data: An application to childhood infectious diseases. Statistics in Medicine, 19, 13-33.
22. Killen, J. D., Fortmann, S. P., Kraemer, H. C., Varady, A. N., Davis, L., & Newman, B. (1996). Interactive effects of depression on symptoms, nicotine dependence, and weight change on late smoking relapse. Journal of Consulting and Clinical Psychology, 64, 1060-1067.
23. Lerman, C., Audrain, J., Orleans, C., Boyd, R., Gold, K., Main, D., & Caporaso, N. (1996). Investigation of mechanisms linking depressed mood to nicotine dependence. Addictive Behaviors, 21, 9-19.
24. Lerman, C., Roth, D., Kaufmann, V., Audrain, J., Hawk, L., Liu, A., Niaura, R., & Epstein, L. (2002). Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug and Alcohol Dependence, 67, 219-223.
25. Livson, N., & Leino, E. (1988). Cigarette smoking motives: Factorial structure and gender differences in a longitudinal study. International Journal of the Addictions, 23, 535-544.
26. Marlatt, G. A., & George, W. H. (1984). Relapse prevention: Introduction and overview of the model. British Journal of Addiction, 79, 261-273.
27. Niaura, R., Britt, D. M., Shadel, W. G., Goldstein, M., Abrams, D., & Brown, R. (2001). Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychology of Addictive Behaviors, 15, 13-17.
28. Perkins, K., Grobe, J., D'Amicao, D., Fonte, C., Wilson, A., & Stiller, R. (1996). Low-dose nicotine nasal spray use and effects during initial smoking cessation. Experimental and Clinical Psychopharmacology, 4, 157-165.
29. Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied psychological Measurement, 1, 385-401.
30. Rogers, W. H. (1993). Regression standard errors in clustered samples. Stata Technical Bulletin, 13, 19-23.
31. Shiffman, S., Johnston, J., Khayrallah, M., Elash, C., Gwaltney, C., Paty, J., Guys, M., Evoniuk, G., & DeVeaugh-Geiss, J. (2000). The effect of bupropion on nicotine craving and withdrawal. Journal of Psychopharmacology, 148, 33-40.
32. Shiffman, S., Paty, J. A., Guys, M., Kassel, J. A., & Hickcox, M. (1996). First lapses to smoking: Within-subjects analysis of real-time reports. Journal of Consulting and Clinical Psychology, 64, 366-379.
33. Swan, G. E., & Denk, C. E. (1987). Dynamic models for the maintenance of smoking cessation: Event history analysis of late relapse. Journal of Behavioral Medicine, 10, 527-554.
34. Swan, G. E., Jack, L. M., & Ward, M. M. (1997). Subgroups of smokers with different success rates after use of transdermal nicotine. Addiction, 92, 207-217.
35. Westman, E. C., Behm, F. M., Simel, D. L., & Rose, J. E. (1997). Smoking behavior on the first day of a quit attempt predicts long-term abstinence. Archives of Internal Medicine, 157, 335-340.
36. Wileyto, E. P., Patterson, F., Niaura, R., Epstein, L. H., Brown, R. A., Audrain-McGovern, J., Hawk, L., Lerman, C., & Patterson, F. (2004). Do small lapses predict relapse to smoking behavior under bupropion treatment? Nicotine & Tobacco Research, 6, 357-367.
37. Williams, R. L. (2000). A note on robust variance estimation for cluster-correlated data. Biometrics, 56, 645-646.